Prognosis

Covid Vaccines for Kids Seen Getting FDA Panel Review in June

Moderna Says Annual Covid Boosters Are Likely to Become Norm
Lock
This article is for subscribers only.

Outside advisers to the U.S. Food and Drug Administration tentatively plan to meet in June to discuss Covid-19 vaccines for younger kids.

The FDA said Friday that it has held the dates of June 8, June 21 and June 22 for potential meetings of its Vaccines and Related Biological Products Advisory Committee to discuss pediatric use of vaccines made by Moderna Inc. and the partnership of Pfizer Inc. and BioNTech SE.